Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2025-12-25 @ 9:18 PM
Study NCT ID:
NCT03455556
Status:
TERMINATED
Last Update Posted:
2023-01-06
First Post:
2018-02-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-10
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-01-07
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-28
First Submit QC Date:
None
Study First Post Date:
2018-03-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-05-01
Results First Submit QC Date:
None
Results First Post Date:
2020-05-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-05
Last Update Post Date:
2023-01-06
Last Update Post Date Type:
ACTUAL